[Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia].
Lebdai S, Rahmène Azzouzi A, Delongchamps NB, Benchikh A, Campeggi A, Cornu JN, Dumonceau O, Faix A, Fourmarier M, Haillot O, Lukacs B, Mathieu R, Misrai V, Robert G, de La Taille A, Descazeaud A.
Lebdai S, et al. Among authors: mathieu r.
Prog Urol. 2015 Jan;25(1):47-53. doi: 10.1016/j.purol.2014.09.049.
Prog Urol. 2015.
PMID: 25453357
French.